Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Prednisolone Acetate 0.5% in Healthy Volunteers
NCT00134992Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisolone in ocular inflammation, sponsored by Novartis. Started Aug 2004; status: completed.
02
Drugs
prednisolone
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT00134992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00134992.